To evaluate the efficacy of Menâ??s Under Eye Serum in reducing the under eye dark circles, puffiness and wrinkles on healthy human male volunteers.
- Registration Number
- CTRI/2012/12/003189
- Lead Sponsor
- ITC RD CENTRE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 35
1.Male subjects in generally good health.
2.Subjects in the age group of 25 to 65 years.
3.17-18 subjects with moderate to severe under eye dark circles, 17-18 Subjects with
puffiness, 17-18 Subjects with moderate to severe fine lines and wrinkles in addition to
either of the above mentioned conditions.
4.Subjects free of any obvious infection of skin as determined by dermatologist.
5.Subject has not participated in a similar investigation in the past four weeks.
6.Subjects have not used a similar product for the last four weeks.
7.Subjects willing to give a written informed consent and come for regular follow up.
1.Subjects with known allergies or sensitivities to cosmetic products, toiletries or its components like fragrances, preservatives, hydroquinone, vitamin C, Niacin amide, retinol, soy etc.
2.Currently or has been using a similar type of product within the last 1 month.
3.Currently or has been undergoing dermatologist skin treatments or procedures within the last 1 month.
4.Currently or has been involved in another skin care clinical investigation within the last 1 months.
5.Subjects who have pre-existing or dormant dermatologic conditions (e.g., psoriasis, rosacea, rashes, eczema, many and/or severe excoriations etc.) that could interfere with the outcome of the study as determined by the investigator.
6.Subjects viewed by the investigator as not being able to complete the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To test the efficacy of investigational formulations in reducing under eye dark circles and puffinessTimepoint: Baseline (week 0), week 1 to week 8
- Secondary Outcome Measures
Name Time Method To test the efficacy of investigational formulations in reducing under eye fine lines and wrinkles.Timepoint: Baseline (week 0), week 1 to week 8